Although the pressures of oncogenic, proliferative stress and genotoxic exposures contribute significantly to the selection of TP53 LOF and signal pathway variants, we suggest that the most prevalent and potent pressure derives from metabolic changes and associated hypoxia and acidosis within the tumour microenvironment. This evidence concerns the gene TP53 and neoplasm.